This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Aortic Endografts Market - 12% Growth During 2012

DUBLIN, March 7, 2013 /PRNewswire/ --

Research and Markets ( http://www.researchandmarkets.com/research/bxcq5h/aortic_endografts) has announced the addition of the "Aortic Endografts Market" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global aortic stent grafts market grew by 12% during 2012 and closed the year touching $1.8 billion in revenue. New generation of lower profile devices were rolled out during the year which further expanded the universe of patients eligible for endovascular repair and the overall market.

According to thought leaders, the years ahead promise to be even more exciting. Paradigms will be shifted and innovation will accelerate to meet the remaining challenges of the aorta and before the end of the decade close to 90% of aortic aneurysm patients will be treated endovascularly.

Aortic Endografts Market attempts to answer some important questions regarding the fast evolving aortic endografts landscape. The report analyzes revenue and growth trends for the entire market with special emphasis on abdominal, thoracic and fenestrated stent graft segments.

Aortic Endografts Market is targeted at senior executives in the medical device industry who wish to get up-to-date with this two billion dollar fast growing market. Key Topics Covered: 1. Executive Summary 2. Aortic Aneurysms 3. Global Aortic Stent Grafts Market 4. Anatomical Segmentation of Aortic Endografts Market 5. Geographical Segmentation of Aortic Endografts Market 6. Aortic Endografts Market Forecast List of Tables & Figures: Companies Mentioned - Altura - Aptus Endosystems - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Lifetech Scientific - Gore Medical - Johnson & Johnson - Jotec - Lombard Medical - Medtronic - Microport Medical - Nano Endoluminal - Terumo - TriVascular For more information visit http://www.researchandmarkets.com/research/bxcq5h/aortic_endografts

Research and Markets Laura Wood, Senior Manager. press@researchandmarkets.com U.S. Fax: +1-646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices, Medical Devices, Cardiovascular Devices

SOURCE Research and Markets

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,086.63 -26.91 -0.16%
S&P 500 1,987.01 +3.48 0.18%
NASDAQ 4,473.6970 +17.6810 0.40%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs